Clinical trial

Embecta AID System in Adults With Type 2 Diabetes

NCT06692153

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2025-01-01

PhaseNA

Study timeline

Study start (estimated)2025-01-01Date precision: month

Registry last updated2024-12-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Type 2 Diabetes Mellitus (T2DM)unresolved

Type 2 DMunresolved

T2DM With Inadequate Glycemic Controlunresolved

T2DM (Type 2 Diabetes Mellitus)unresolved

T2Dunresolved

T2DMunresolved

Interventions

An AID System.DEVICE

Standard of Care (SC)OTHER

Sponsors & collaborators

Embecta Corp.lead sponsor

Jaeb Center for Health Researchcollaborator

Mapped research locations

New YorkNew York, United States1 DallasTexas, United States1 IndianapolisIndiana, United States1 Palo AltoCalifornia, United States1 Walnut CreekCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06692153 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.